Technical Analysis for CVM - Cel-Sci Corporation

Grade Last Price % Change Price Change
grade B 3.02 4.14% 0.12
CVM closed up 4.14 percent on Monday, March 18, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CVM trend table...

Date Alert Name Type % Chg
Mar 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 18 Upper Bollinger Band Walk Strength 0.00%
Mar 18 Upper Bollinger Band Touch Strength 0.00%
Mar 15 Upper Bollinger Band Walk Strength 4.14%
Mar 15 Outside Day Range Expansion 4.14%
Mar 15 Upper Bollinger Band Touch Strength 4.14%
Mar 14 Narrow Range Bar Range Contraction -1.31%
Mar 14 NR7 Range Contraction -1.31%
Mar 14 Upper Bollinger Band Walk Strength -1.31%
Mar 14 Inside Day Range Contraction -1.31%

Older signals for CVM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company's principal product, Multikine, is under Phase III clinical trial for the treatment of head and neck cancer. The Multikine is an immunotherapeutic agent consisting of a mixture of cytokines that produce an anti-tumor immune response. It also develops Ligand Epitope Antigen Presentation System (LEAPs), a heteroconjugate technology that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune, allergies, transplantation rejection, and cancer. The company, through its LEAPS technology, develops a peptide treatment for H1N1 hospitalized patients; and CEL-2000, a rheumatoid arthritis vaccine. CEL-SCI Corporation was founded in 1983 and is based in Vienna, Virginia.
Medicine Cancer Medical Specialties Immunology Immunotherapy Immune System Rheumatoid Arthritis Vaccination Autoimmunity Transplantation Vaccine Head And Neck Cancer Allergies Treatment Of Head And Neck Cancer
Is CVM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.44
52 Week Low 0.82
Average Volume 281,563
200-Day Moving Average 2.6544
50-Day Moving Average 2.8112
20-Day Moving Average 2.843
10-Day Moving Average 2.925
Average True Range 0.1904
ADX 16.1
+DI 19.071
-DI 16.3359
Chandelier Exit (Long, 3 ATRs ) 2.6188
Chandelier Exit (Short, 3 ATRs ) 2.9412
Upper Bollinger Band 3.0724
Lower Bollinger Band 2.6136
Percent B (%b) 0.89
BandWidth 16.137883
MACD Line 0.0472
MACD Signal Line 0.0223
MACD Histogram 0.0249
Fundamentals Value
Market Cap 28.19 Million
Num Shares 9.33 Million
EPS -1.54
Price-to-Earnings (P/E) Ratio -1.96
Price-to-Sales 102.40
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.38
Resistance 3 (R3) 3.37 3.25 3.32
Resistance 2 (R2) 3.25 3.15 3.25 3.30
Resistance 1 (R1) 3.13 3.10 3.07 3.14 3.28
Pivot Point 3.01 3.01 2.98 3.01 3.01
Support 1 (S1) 2.89 2.91 2.83 2.90 2.76
Support 2 (S2) 2.77 2.86 2.77 2.74
Support 3 (S3) 2.65 2.77 2.72
Support 4 (S4) 2.66